Expanding the applicability of noninvasive fibrosis markers in HIV/HCV co-infected patients [2]

Hepatology

Volumn 45, Issue 1, 2007, Pages 257-258

  Schiavon, Leonardo L ^a   Carvalho Filho, Roberto J ^a   Narciso, Janaína L ^a   Sampaio, Juliana P ^a   Lanzoni, Valéria P ^a   Ferraz, Maria Lucia G ^a   Silva, Antonio Eduardo B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE;

ANTIVIRAL THERAPY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME ACTIVITY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MORBIDITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

AGE FACTORS; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; PLATELET COUNT; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 33846436029     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21507     Document Type: Letter

References (7)

1. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-Garcia J, Lazzarin A, et al; APRICOT Study Group. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004;351:438-450.
2. Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, et al; AIDS Clinical Trials Group A5071 Study Team. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004;351:451-459.
3. Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, et al; ANRS HCO2 RIBAVIC Study Team. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004;292:2839-2848.
4. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
5. Soto B, Sanchez-Quijano A, Rodrigo L, del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1-5.
6. Rockstroh JK, Spengler U, Sudhop T, Ewig S, Theisen A, Hammerstein U, et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996;91:2563-2568.
7. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. HEPATOLOGY 2006;43:1317-1325.